Eberhard Spanuth

Title: Eberhard Spanuth: Innovator in Cardiovascular Diagnostics

Introduction

Eberhard Spanuth is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of cardiovascular diagnostics, holding a total of 6 patents. His work focuses on innovative methods for diagnosing and evaluating cardiovascular diseases.

Latest Patents

One of his latest patents is titled "Use of sCD14 or its fragments or derivatives for risk stratification, diagnosis and prognosis." This invention relates to a method for diagnosing cardiovascular diseases or conditions, including atherosclerosis. It also evaluates the risk of a subject developing such conditions. The invention provides methods for assessing a subject's risk of mortality and determining whether they will benefit from specific treatments or require hospitalization. The patent highlights sCD14 or its derivatives as novel markers for cardiovascular risk.

Another significant patent is the "Method for prediction of prognosis of sepsis." This method involves measuring sCD14-ST levels in a sample, which serves as a superior marker compared to procalcitonin for predicting the prognosis in sepsis patients.

Career Highlights

Eberhard Spanuth has worked with prominent companies in the diagnostics field, including Roche Diagnostics Operations, Inc. and Roche Diagnostics GmbH. His experience in these organizations has contributed to his expertise in developing innovative diagnostic methods.

Collaborations

Throughout his career, Spanuth has collaborated with notable colleagues, including Boris Ivandic and Christian Hamm. These partnerships have likely enhanced his research and development efforts in the field of cardiovascular diagnostics.

Conclusion

Eberhard Spanuth's contributions to cardiovascular diagnostics through his patents and collaborations highlight his role as an innovator in the medical field. His work continues to impact the diagnosis and treatment of cardiovascular diseases.